ABL1 and renal fibrosis: Finally, our results demonstrated that myofibroblast-specific deletion of c-Abl effectively mitigates the development and progression of kidney fibrosis in mice, suggesting that targeting c-Abl could serve as a novel and potent approach for the treatment of renal fibrosis and preservation of kidney function.